Pilot and Feasibility Program

试点和可行性计划

• 批准号: 9186888
• 负责人: Arshiya Ahmed Baig
• 金额: $ 9.99万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9186888
• 关键词: Applications Grants; Area; Asian Americans; Award; Biological Sciences; Car Phone; Caring; Chicago; Clinical; Collaborations; Community Health; Data; Diabetes Mellitus; Ecology; Elderly; End stage renal failure; Evidence based intervention; Fostering; Funding; Funding Mechanisms; Future; Generations; Grant; Institution; Intervention; N.I.H. Research Support; National Institute of Diabetes and Digestive and Kidney Diseases; Nature; Non-Insulin-Dependent Diabetes Mellitus; Outcome; Patient Care; Patients; Peer Review; Population; Publications; Recording of previous events; Research; Research Personnel; Research Support; Research Training; Scientist; Secure; Sleep; Testing; Translating; Translational Research; Translations; United States Agency for Healthcare Research and Quality; Universities; Vulnerable Populations; Woman; Work; abstracting; base; behavioral outcome; career; clinical practice; community based participatory research; diabetic; health economics; improved; improved outcome; innovation; interest; malignant breast neoplasm; medical specialties; novel; population health; programs; sedentary lifestyle; shared decision making; success

PROJECT SUMMARY – Pilot and Feasibility Program The Pilot and Feasibility grant program at the Chicago Center for Diabetes Translation Research (CCDTR) supports new areas of inquiry in diabetes-related translation research, with a special focus on vulnerable populations. The main aim of P&F program is to provide funding for investigators to explore novel hypotheses and to obtain preliminary data in order to secure long-term support from conventional funding mechanisms. Funding from the P&F program has supported new investigators who are seeking to become fully independent scientists in diabetes translation research and established investigators who are seeking to initiate diabetes- related research. Since its inception in 2011, the CCDTR P&F program has received 20 applications and has awarded 11 grants. Thus far these pilot grants have led to 15 abstract presentations, 4 peer-reviewed publications, and 10 grant applications submitted, with subsequent funding of 6 grants from the NIDDK, NHBLI, and AHRQ. The P&F program has made a difference for many investigators and has launched the careers of several investigators in the fields of diabetes translational research. Our breadth of funding is demonstrated in the number of institutions and types of interventions funded. About 40% of grantees are from outside the University of Chicago. The grantees' areas of study have included assessments of sleep interventions to improve diabetic outcomes, improving care of patients with pre-end-stage kidney disease, community health worker interventions, mobile phone interventions on sedentary behavior, and outcomes of women with type 2 diabetes and breast cancer. Looking forward, we plan to continue our successful P&F program, which has been an integral part of the CCDTR in fostering collaboration and has led to important research findings, and further expand its scope. We are requesting continuing support at the level of $50,000 per year. The Dean of the Biological Sciences Division, Kenneth Polonsky, MD, will continue his support by providing $50,000 in matching funds per year towards the P&F program. This supplemental funding will allow us to grant four awards of $25,000 per year. We also plan to diversify the areas of translation research funded by encouraging applications that study diverse types of interventions (e.g. interventions to improve population health), the populations studied (e.g. Asian American populations and LGBTQ patients), and the fields of expertise of the grantees (e.g. environmental science, breadth of clinical specialties and subspecialties). The success of our P&F program to date is a reflection of the interdisciplinary nature of our center and the strong research base it provides. Through a renewal of the CCDTR, the P&F program will be able to continue to provide necessary funding support to a new generation of innovative and diverse diabetes translation researchers and increase their chances of securing long-term funding in the future.

项目总结--试点和可行性方案 芝加哥糖尿病翻译研究中心(CCDTR)的试点和可行性赠款计划 支持糖尿病相关翻译研究的新领域，特别关注弱势群体 人口。P&F计划的主要目的是为研究人员探索新的假说提供资金 并获得初步数据，以确保从传统筹资机制获得长期支持。 来自P&F项目的资金支持了寻求完全独立的新调查人员 糖尿病翻译研究的科学家和寻求启动糖尿病的知名研究人员- 相关研究。自2011年启动以来，CCDTR P&F计划已收到20份申请，并已 授予11项奖助金。到目前为止，这些试点赠款已经产生了15个摘要报告，4个同行评审 出版物，并提交了10份赠款申请，随后由NIDDK、NHBLI、 和AHRQ。P&F项目对许多调查人员产生了影响，并启动了 糖尿病转化研究领域的几位研究人员。我们资金的广度体现在 所资助的机构数量和干预措施类型。约40%的受赠人来自 芝加哥大学。受赠者的研究领域包括对睡眠干预的评估 改善糖尿病预后、改善对终末期肾病前期患者的护理、社区健康 工作人员干预、移动电话干预对2型女性久坐行为和结局的影响 糖尿病和乳腺癌。展望未来，我们计划继续我们成功的P&F计划，该计划已 在促进合作方面是CCDTR不可或缺的一部分，并产生了重要的研究成果，以及 进一步扩大范围。我们请求继续提供每年50,000美元的支助。香港中文大学教务长 医学博士肯尼斯·波隆斯基的生物科学部将继续提供50,000美元的支持 每年用于P&F计划的匹配资金。这笔补充资金将使我们能够授予四名 每年25,000美元的奖金。我们还计划使翻译研究的领域多样化，通过鼓励 研究不同类型干预措施(例如，改善人口健康的干预措施)的应用程序， 研究人群(例如亚裔美国人和LGBTQ患者)，以及 受赠者(例如，环境科学、临床专业和亚专业的广度)。我们的成功 到目前为止，P&F项目反映了我们中心的跨学科性质和强大的研究基础 提供了。通过续签CCDTR，P&F计划将能够继续提供必要的 为新一代创新和多样化的糖尿病翻译研究人员提供资金支持并增加 他们在未来获得长期资金的机会。